Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 49 recruiting now official registry

Diabetes Mellitus clinical trials

Every US clinical trial registered for Diabetes Mellitus — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

210 US clinical trials · 49 currently recruiting

The research picture

Diabetes Mellitus has 210 registered US clinical trials, 49 of them open to new participants right now — about 23% of the total.

49
recruiting participants now
23%
of trials open to enrollment
26
in Phase 3–4 (later-stage)
8
top sponsor: Takeda

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING 100,000 participants

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00342927

RECRUITING 50,000 participants

The T1D Exchange Registry

T1D Exchange, United States

NCT04629586

RECRUITING 19,331 participants

Examining Digital Health Care Delivery Models Through Medicaid Collaborative

OSF Healthcare System

NCT05555095

RECRUITING 5,000 participants

Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study

Washington University School of Medicine

NCT02841553

RECRUITING 4,000 participants

Genetics Of Autoimmunity In Type I Diabetes

Medical College of Wisconsin

NCT03648918

RECRUITING 2,000 participants

Rare and Atypical Diabetes Network

University of South Florida

NCT05544266

RECRUITING 1,500 participants

Early Tracking of Childhood Health Determinants (ETCHED) Study

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT03481829

RECRUITING 1,200 participants

Genetic Studies of Insulin and Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00001987

RECRUITING NA 1,200 participants

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

Dartmouth-Hitchcock Medical Center

NCT05955339

RECRUITING NA 978 participants

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

California Polytechnic State University-San Luis Obispo

NCT06988306

RECRUITING 800 participants

Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

Abbott Diabetes Care

NCT06668935

RECRUITING NA 798 participants

Care Transitions App for Patients With Multiple Chronic Conditions

Brigham and Women's Hospital

NCT06051058

RECRUITING 500 participants

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

University of New Mexi

NCT04185844

RECRUITING 350 participants

Inflammation, Diabetes, Ethnicity and Obesity Cohort

University of California, San Francis

NCT03022682

RECRUITING NA 318 participants

Increasing CGM Use Among Patients With T2D

San Diego State University

NCT06638099

RECRUITING NA 300 participants

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Aventyn

NCT07403669

RECRUITING NA 256 participants

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

University of North Carolina, Chapel Hill

NCT06724406

RECRUITING Phase 2 240 participants

Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women

Arizona State University

NCT06337708

RECRUITING NA 240 participants

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

University of Colorado, Denver

NCT07011147

RECRUITING Phase 3 230 participants

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Energenesis Biomedical Co.

NCT05930210

RECRUITING Phase 2 200 participants

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

University of Alabama at Birmingham

NCT04055428

RECRUITING NA 200 participants

ED Diabetes Screening and Outpatient Care

NYU Langone Health

NCT05899023

RECRUITING NA 200 participants

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

University of North Carolina, Chapel Hill

NCT06405373

RECRUITING NA 192 participants

Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Nationwide Children's Hospital

NCT03622359

RECRUITING NA 177 participants

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

C5 Biomedical

NCT06674980

RECRUITING NA 175 participants

SPYRAL GEMINI Pilot Study

Medtronic Vascular

NCT06907147

RECRUITING Phase 2 150 participants

Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia

Mayo Clinic

NCT03865290

RECRUITING Phase 4 150 participants

Impact GLP-1 Agonists Following Bariatric

University of Missouri-Columbia

NCT06132477

RECRUITING NA 150 participants

Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control

Mayo Clinic

NCT07006480

RECRUITING 120 participants

The Diabetes Staging System in Patient Aligned Care Teams

Durham VA Medical Center

NCT06142006

RECRUITING NA 120 participants

A Fruit and Vegetable Prescription Program

Milton S. Hershey Medical Center

NCT06107816

RECRUITING NA 100 participants

Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility

Hamad Medical Corporation

NCT05407207

RECRUITING NA 100 participants

Texts for Diabetes Control Among Homeless Persons

George Washington University

NCT05616026

RECRUITING NA 100 participants

Total Contact Soft Cast in Diabetic Foot Ulcers

University of Minnesota

NCT04210089

RECRUITING Phase 2 100 participants

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

Massachusetts General Hospital

NCT05866536

RECRUITING NA 100 participants

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

Mayo Clinic

NCT05880810

RECRUITING NA 72 participants

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

University of Connecticut

NCT07238556

RECRUITING NA 54 participants

Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation

VA Office of Research and Development

NCT03995238

RECRUITING NA 50 participants

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

University of Maryland, Baltimore

NCT06918977

RECRUITING NA 48 participants

Full Plate Living Nutrition Education Program

University of Wisconsin, Madison

NCT07271940

RECRUITING Phase 2 42 participants

Sleep, Diabetic Retinopathy and Melatonin

University of Illinois at Chicago

NCT04547439

RECRUITING Phase 2 40 participants

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Mayo Clinic

NCT06729996

RECRUITING NA 40 participants

Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

Matthew Allemang

NCT04696159

RECRUITING 37 participants

This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device

Cedars-Sinai Medical Center

NCT06965803

RECRUITING Phase 3 28 participants

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

University of Oklahoma

NCT05174052

RECRUITING NA 25 participants

Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy

Florida Institute for Human and Machine Cognition

NCT06591780

RECRUITING 25 participants

Diabetic Neuropathy in Spinal Cord Stimulator Patients

University of Chicago

NCT04687215

RECRUITING NA 20 participants

Screening and Nutrition for Patients With Diabetes: A Pilot Study

Villanova University

NCT05674110

RECRUITING Phase 1 18 participants

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

NCT06623396

ACTIVE NOT RECRUITING NA 8,869 participants

Early Detection Initiative for Pancreatic Cancer

Pancreatic Cancer Action Network

NCT04662879

ACTIVE NOT RECRUITING 5,888 participants

Cardiovascular Health Study (CHS)

National Heart, Lung, and Blood Institute (NHLBI)

NCT00005133

ACTIVE NOT RECRUITING NA 2,177 participants

Eat Well Produce Benefit for Diabetes and Food Insecurity

Duke University

NCT05896644

ACTIVE NOT RECRUITING NA 1,300 participants

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Medtronic Vascular

NCT05198674

ACTIVE NOT RECRUITING NA 542 participants

Dissemination of the Cardiovascular Risk Service

Korey Kennelty

NCT03660631

ACTIVE NOT RECRUITING 500 participants

Biological Sample Repository for Gastrointestinal Disorders

Pichamol Jirapinyo, MD, MPH

NCT05874726

ACTIVE NOT RECRUITING NA 347 participants

Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities

City of Hope Medical Center

NCT05414396

ACTIVE NOT RECRUITING Phase 4 255 participants

Oral Anti Diabetic Agents in the Hospital

Emory University

NCT04416269

ACTIVE NOT RECRUITING NA 185 participants

Texting for Diabetes

St. Louis University

NCT03025984

ACTIVE NOT RECRUITING NA 122 participants

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes

Joslin Diabetes Center

NCT05337826

ACTIVE NOT RECRUITING Phase 4 121 participants

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT03520660

ACTIVE NOT RECRUITING NA 120 participants

Black Girls Move Physical Activity and Improving Dietary Intake Among Black Adolescent Daughters

Rush University Medical Center

NCT05433415

ACTIVE NOT RECRUITING 75 participants

Glucose Metabolism in Sickle Cell Disease

University of Illinois at Chicago

NCT02922296

ACTIVE NOT RECRUITING NA 48 participants

A Sugar-Sweetened Beverage Reduction Intervention for Native American Men

Roswell Park Cancer Institute

NCT06029517

ACTIVE NOT RECRUITING NA 40 participants

Continuous Glucose Monitoring of Hospitalized Patients With Diabetes

Baylor Research Institute

NCT04230694

ACTIVE NOT RECRUITING NA 40 participants

Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations

Marshall University

NCT02336217

ACTIVE NOT RECRUITING NA 37 participants

Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome

Rutgers, The State University of New Jersey

NCT06461273

ACTIVE NOT RECRUITING NA 35 participants

Study of a Primary Care Hypoglycemia Prevention Program

Johns Hopkins University

NCT06353217

ACTIVE NOT RECRUITING NA 28 participants

Community Health Workers in Pediatric Patients With Newly Diagnosed Type 1 Diabetes

Children's Hospital of Philadelphia

NCT04238949

ACTIVE NOT RECRUITING NA 25 participants

Plant-based Diet for Kidney Transplant Recipients

George Washington University

NCT06186843

ACTIVE NOT RECRUITING NA 20 participants

Enhancing Mental and Physical Health of Women Veterans

VA Office of Research and Development

NCT05050266

ACTIVE NOT RECRUITING Phase 1 17 participants

Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

City of Hope Medical Center

NCT00706420

COMPLETED 57,073 participants

Evaluation of VLER-Indiana Health Information Exchange Demonstration Project

VA Office of Research and Development

NCT01446705

COMPLETED 28,813 participants

Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program

Brigham and Women's Hospital

NCT03326206

COMPLETED NA 13,155 participants

Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record

University of Utah

NCT03826290

COMPLETED Phase 3 10,251 participants

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

National Heart, Lung, and Blood Institute (NHLBI)

NCT00000620

COMPLETED NA 9,501 participants

Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications

University of Colorado, Denver

NCT03973931

COMPLETED NA 7,052 participants

Blood Glucose Monitoring in Electronic Health Records

Inova Health Care Services

NCT03542487

COMPLETED 6,000 participants

Improving Diabetes in Primary Care (IMPACT)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00108927

COMPLETED NA 5,000 participants

Clinical Decision Support for Medication Management and Adherence

Duke University

NCT00979225

COMPLETED NA 4,994 participants

Glucose to Goal: A Model to Support Diabetes Management in Primary Care

University of Pittsburgh

NCT02715934

COMPLETED NA 3,000 participants

Improving Quality With Outpatient Decision Support

Agency for Healthcare Research and Quality (AHRQ)

NCT00225628

COMPLETED NA 2,000 participants

Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes

US Department of Veterans Affairs

NCT00119535

COMPLETED NA 1,665 participants

Randomized Trial of Telemedicine for Diabetes Care

Columbia University

NCT00271739

COMPLETED NA 1,485 participants

Diabetes-Depression Care-management Adoption Trial

University of Southern California

NCT01781013

COMPLETED Phase 3 1,100 participants

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Pfizer

NCT00134147

COMPLETED Phase 3 803 participants

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Takeda

NCT00432276

COMPLETED NA 773 participants

Integrating Community Health Workers to Improve Diabetes Prevention

NYU Langone Health

NCT03006666

COMPLETED 750 participants

CV Disease in Adolescents With Type 2 Diabetes

Children's Hospital Medical Center, Cincinnati

NCT00114998

COMPLETED Phase 3 719 participants

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Takeda

NCT00331487

COMPLETED Phase 2 699 participants

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

Tris Pharma

NCT01939366

COMPLETED Phase 3 695 participants

Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo

AstraZeneca

NCT02229396

COMPLETED NA 650 participants

Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge

Kaiser Permanente

NCT04351880

COMPLETED 628 participants

Evaluation of the Analytical Performance of ALLEGRO™ Instrument

Nova Biomedical

NCT04096313

COMPLETED 621 participants

Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00001859

COMPLETED Phase 3 600 participants

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

Takeda

NCT00727857

COMPLETED NA 550 participants

Effect of Care Management on Diabetes Outcomes

Minneapolis Veterans Affairs Medical Center

NCT00569556

COMPLETED NA 550 participants

Multidisciplinary Inpatient Palliative Care Intervention

Kaiser Permanente

NCT00325611

COMPLETED Phase 3 547 participants

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Takeda

NCT00225277

COMPLETED NA 543 participants

User Evaluation of the Invasive Component of the CNOGA TensorTip COMBO GLUCOMETER (CoG)

Sciema UG

NCT03870971

COMPLETED Phase 3 527 participants

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Takeda

NCT00286442

Phase Distribution

PhaseTrial count
Phase 1 13
Phase 2 19
Phase 3 18
Phase 4 8

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Diabetes Mellitus Trial Landscape

ClinicalTrials.gov lists 210 US studies indexed under Diabetes Mellitus, and 49 of those are currently open to recruitment — roughly 23% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Diabetes Mellitus shows 26 late-stage studies (Phase 3 and Phase 4 combined) alongside 32 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Diabetes Mellitus is led by Takeda with 8 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 100 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Diabetes Mellitus?

PlainTrial tracks 210 US clinical trials for Diabetes Mellitus, of which 49 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Diabetes Mellitus?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →